Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0383819720190020035
Tuberculosis and Respiratory Diseases
1972 Volume.19 No. 2 p.35 ~ p.38
The Clinical Effect of Rifampicin for Retreatment Cases for Pulmonary Tuberculosis




Abstract
The authors analyzed the clinical benefits and toxic effects of Rifampicin in 32
patients with prolonged previous chemotherapy without effect (5cases were
post-operative). The Rifampicin was given with one or more other anti-Tb. drugs (or 3
to 12 months. The doses were 450-600§· once daily or biweekly.
Sputum conversion: 14 patients had positive sputum on the begining and 7 patients
(50%) became nagative with Rifampicin treatment.
X-ray improvement There was no remarkable change noticed except slight
improvement in 7 cases.
Symptomatic improvement : Majority of cases showed a decrease of cough and sputm
souse of wellbeing, soon after the administration of Rifampicin and also showed some
gain of badyweight.
Side effects: There was no serious side effect and serious liver function disturbance
detected but one case had chill, fever and general bodyache and another case complained
of general bodyache 6 to 7 months after the Rifampicin treatment.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø